A recent commentary published in the medical journal JAMA highlights a growing reality: AI is increasingly surpassing human physicians in certain medical diagnoses and treatment support. In light of this technological evolution, the article argues for a reevaluation of the mandatory application of "human-in-the-loop" (human oversight) currently heavily enforced by regulatory authorities.
Rather than announcing a new product, this paper serves as an important academic proposal regarding the future framework of medical AI regulation. It raises a critical question: in a future where AI-driven diagnosis becomes standardized, is requiring human intervention and approval for every decision truly enhancing patient safety? The authors suggest that excessive human intervention may instead pose a risk of creating operational bottlenecks.
This discussion is underpinned by the fact that AI has already achieved accuracy rates exceeding those of humans in specific diagnostic tasks. While traditional medical regulatory frameworks generally treat AI strictly as a "physician's assistant," the commentary notes that in environments where AI alone can outperform doctors, forced human intervention could paradoxically induce errors or significantly impair the promptness of diagnoses.
The paper's authors argue that processes mandating human re-checks of AI decisions lead to an underestimation of the technology's benefits. Moving forward, there is an urgent need to build new regulatory models that assume AI's autonomous decision-making capabilities while ensuring safety and clarifying where liability lies.